| 1 |
Karcic E, Aljicevic M, Bektas S, Karcic B. Antimicrobial Susceptibility/Resistance of Streptococcus Pneumoniae. Mater Sociomed 2015;27:180-4. [PMID: 26236165 DOI: 10.5455/msm.2015.27.180-184] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Ludwig E, Jorgensen L, Gray S, Munson S, Chou K, Gutterman EM. Clinical burden of multi-cause and pneumococcal pneumonia, meningitis, and septicemia in Hungary. Results of a retrospective study (2006–2011). Orvosi Hetilap 2014;155:1426-36. [DOI: 10.1556/oh.2014.29990] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 3 |
Schnappauf C, Rodloff A, Siekmeyer W, Hirsch W, Sorge I, Schuster V, Kiess W. Invasive pneumococcal diseases in children and adolescents--a single centre experience. BMC Res Notes 2014;7:145. [PMID: 24625087 DOI: 10.1186/1756-0500-7-145] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 4 |
Sime WT, Aseffa A, Woldeamanuel Y, Brovall S, Morfeldt E, Henriques-Normark B. Serotype and molecular diversity of nasopharyngeal Streptococcus pneumoniae isolates from children before and after vaccination with the ten-valent pneumococcal conjugate vaccine (PCV10) in Ethiopia. BMC Infect Dis 2019;19:409. [PMID: 31077141 DOI: 10.1186/s12879-019-4024-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 5 |
Wrotek A, Jackowska T. The role of the soluble urokinase plasminogen activator (suPAR) in children with pneumonia. Respir Physiol Neurobiol 2015;209:120-3. [PMID: 25602915 DOI: 10.1016/j.resp.2014.12.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 6 |
Jauneikaite E, Jefferies JM, Hibberd ML, Clarke SC. Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: a review. Vaccine 2012;30:3503-14. [PMID: 22475858 DOI: 10.1016/j.vaccine.2012.03.066] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 7 |
Tin Tin Htar M, Madhava H, Balmer P, Christopoulou D, Menegas D, Bonnet E. A review of the impact of pneumococcal polysaccharide conjugate vaccine (7-valent) on pneumococcal meningitis. Adv Ther 2013;30:748-62. [PMID: 24000099 DOI: 10.1007/s12325-013-0051-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
|
